← Evidence map

ReviewJournal of enzyme inhibition and medicinal chemistry2025

The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.

Peng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40891362